Viridian Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Highlights Progress in Thyroid Eye Disease Pipeline Oppenheimer Holdings Inc Q1 2025 Earnings Solid EPS Amid Quiet Revenue Disclosure Stock Slips UBFO Q4 2025 Earnings Solid EPS of 019 Reported Shares Remain Flat PCOR Q1 2026 Earnings EPS Misses Estimates Despite Modest Stock Gains FTFT Q2 2024 Earnings Narrowing Losses Amidst Strategic Transformation in Blockchain and Fintech TME Q1 2026 Earnings EPS Beat Fails to Lift Shares